A Flagship VentureLabs Company

Pronutria Biosciences

840 Memorial Drive
3rd Floor

Cambridge, MA  02139

Tel: 617.868.0949

Robert Connelly


Pronutria Biosciences

Flagship Partners:  Noubar Afeyan, David Berry
Initial Investment: 

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics.  Amino acids (AA) are known as the “building blocks of life,” and are fundamental regulators of health. The entire body, ranging from microscopic cells to organs, is dependent on tightly controlled AA homeostasis.  More than 2000 disorders are linked to differences in AA metabolism and transport.  The dysregulation of AAs cause and/or drive the onset of a number of conditions.  Using insights from a clinically validated body of evidence, Pronutria Biosciences is developing first-in-class therapeutic and nutritional solutions to these conditions with a focus on amino acid biology. This novel approach allows us to precisely target biology that was previously inaccessible, providing a unique opportunity to address a variety of serious nutritional and medical conditions, such as muscle, metabolic, neurological, and hepatic disorders.

Noubar Afeyan is Chairman and David Berry is on the Board of Directors.